SEER - Seer Bio Company Value to Earnings Growth Ratio

Brandmark of Seer, Inc. (SEER)

Seer, Inc. (SEER) develops innovative protein study systems for American research centers. The PEG ratio illustrates the dynamics of the stock price relative to earnings, where 0.00 describes the current status of the metric. Business efficiency is based on the demand for consumables and the speed of proteome analysis. Growing demand from pharmaceutical laboratories for biomarker discovery ensures the company's sustainable development.

Seer Inc. (SEER): PEG Multiple from 07/04/2022 to 11/11/2026

Metric breakdowns and analytics for Seer, Inc. (SEER)

- price and consensus price forecast:
Market Chart Seer Inc|SEER - Consensus Target
- market capitalization statistics:
Market Value Seer Inc.|SEER - Enterprise Value
- book capitalization information:
Net Assets per Share Seer|SEER - Book Capitalization|Market Cap to Net Assets Ratio seer.bio|SEER - Cumulative Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Seer, Inc.|SEER - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio seer.bio|SEER - Company Aggregate Debts|Debts to Book Value Seer Inc.|SEER - Company Long-Term Debts|Company Short-Term Indebtedness Seer|Interim Coverage Ratio seer.bio
- net income and valuation ratios data:
SEER - Net Profit|Future Profit Seer, Inc.|SEER - P/E Multiple|Forward P/E Multiple Seer Bio|SEER - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Seer Inc.|SEER - Operating profit before deduction of amortization|Earnings per share for the trailing year Seer|SEER - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months seer.bio|SEER - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Seer, Inc.
General company analysis:SEER - Seer Inc
Finished products of Seer

The technological resilience of Seer, Inc. (SEER), underpinned by high-precision facilities in California and component reserves, establishes a foundation for revenue scaling. By analyzing this growth stock attractiveness indicator, an investor assesses the PEG ratio (P/E to earnings growth); values below one signal that the asset is undervalued relative to its expansion, confirming the fundamental strength of the business model.

Competing companies

Growth-Adjusted Market Cap to Net Income Abbott Labs|Thermo Fisher Corp - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio GEHC (GE HealthCare Inc.)|Mettler-Toledo International - PEG Multiple|Growth-Adjusted Market Cap to Net Income waters.com WAT|TECH: PEG Multiple|Price/Earnings to Growth Multiple Bruker Corp|Price/Earnings to Growth Multiple AZTA|VREX: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Semler Scientific, Inc. (SMLR)|Price/Earnings to Growth Multiple butterflynetwork.com BFLY|PEG Multiple MLAB (Mesa Labs)|Quantum-Si Inc. (QSI) - Price to Earnings Adjusted for Growth Rate|Nanox - PEG Multiple|QTRX (Quanterix Inc) - Growth-Adjusted P/E Ratio|MASS: PEG Multiple|CV - Growth-Adjusted Market Cap to Net Income|MXCT (MaxCyte) - PEG Multiple|Price/Earnings to Growth Multiple Rapid Micro (RPID)|PEG Multiple HYPR|PEG Multiple FONAR Corporation Inc (FONR)|Price/Earnings to Growth Ratio Daxor DXR|Spectral AI Inc. - Price/Earnings to Growth Ratio|VIVS: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio ACON (Aclarion Inc)|AKYA: PEG Multiple|Price to Earnings Adjusted for Growth Rate Cesca Therapeutics (THMO)|Price/Earnings to Growth Ratio Talis Biomedical Corp.|TTOO - Price to Net Income Growth Ratio